Osimertinib vs Rituximab

## Osimertinib vs Rituximab: Overview

This comparison examines the pharmacological differences between **Osimertinib** and **Rituximab**.

## Mechanism of Action

**Osimertinib**: Third-generation irreversible EGFR TKI targeting T790M resistance mutation and activating mutations.

**Rituximab**: Chimeric anti-CD20 IgG1 monoclonal antibody inducing B-cell depletion via CDC, ADCC, and apoptosis.

## Pharmacokinetics

**Half-life**: Osimertinib — 48 hours; Rituximab — 22 days.

## Chemical Properties

**Molecular Formula**: Osimertinib — C28H33N7O2; Rituximab — N/A.

**Molecular Weight**: Osimertinib — 499.6050 g/mol; Rituximab — N/A.

**Type**: Osimertinib — Small molecule; Rituximab — Antibody.